Related Experiment Videos
[Ventilator associated pneumonia]
S Bellani1, M Nesci, S Celotto
1Servizio di Anestesia e Rianimazione, Azienda Ospedaliera San Gerardo, Monza, Italia.
Minerva Anestesiologica
|May 27, 2003
Summary
Ventilator-associated pneumonia (VAP) is a serious infection in mechanically ventilated patients. Preventing, diagnosing, and treating VAP are crucial for improving patient outcomes and reducing mortality.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Respiratory Therapy
Context:
- Ventilator-associated pneumonia (VAP) is a common nosocomial infection in critically ill patients on mechanical ventilation.
- VAP incidence ranges from 9% to 68%, with mortality rates between 33% and 71%.
Purpose:
- To highlight the pathogenesis of VAP, emphasizing bacterial colonization and aspiration.
- To underscore the importance of preventive strategies like selective digestive decontamination (SDD), supraglottic aspiration, and patient positioning.
- To stress the significance of early VAP recognition and treatment for improved patient outcomes.
Summary:
- VAP pathogenesis involves bacterial colonization of the upper airway and aspiration of secretions.
- Preventive measures include SDD, supraglottic aspiration, and proper patient positioning.
- Prompt diagnosis and treatment of VAP are essential for managing mechanically ventilated patients.
Impact:
- Implementing preventive strategies can reduce VAP incidence.
- Early detection and treatment of VAP significantly improve patient survival rates.
- Knowledge of VAP risk factors and management is vital for critical care nursing.